Pune: Amid the growing burden of cardiovascular disease, Sahyadri Super Speciality Hospital, Pune, said it is increasingly relying on advanced cardiac laser therapy to treat patients with complex coronary artery disease where conventional interventions may not be sufficient.
According to the hospital, the technology is being used to manage patients who have previously undergone angioplasty but later developed recurring blockages, narrowed or failed stents, and other challenging coronary conditions requiring repeat intervention.
The hospital said the minimally invasive therapy can help restore blood flow, facilitate faster recovery, and, in selected cases, reduce the need for additional stents or bypass surgery.
It added that the impact of the therapy has been observed across different age groups, citing examples of a 76-year-old and a 21-year-old patient who were able to avoid further complications and more invasive procedures.
Dr. Abhijeet Palshikar, Director – Cardiology, Sahyadri Super Speciality Hospital, said, “As more patients undergo angioplasty and live longer after their initial treatment, we are witnessing a rise in complex coronary artery disease requiring repeat intervention.
“Advanced cardiac laser technology has significantly strengthened our ability to manage these challenging cases with greater precision. We are increasingly utilising this technique for specialised redo angioplasties where previously implanted stents have failed, enabling effective treatment while helping many patients avoid bypass surgery.”
Dr. Nilesh Singh, Hospital Director, Sahyadri Super Speciality Hospital, Deccan Gymkhana, said, “The introduction of advanced cardiac laser technology reflects our focus on expanding access to contemporary cardiovascular care for patients.
“This approach has supported the management of complex coronary conditions through a minimally invasive technique. Such innovations contribute to improved clinical outcomes and patient experience while helping reduce the need for repeat interventions in appropriate cases. Over time, this has enabled us to support patients across diverse clinical profiles with increasingly specialised cardiac care.”
